Cargando…

PITPs as Targets for Selectively Interfering With Phosphoinositide Signaling in Cells

Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production, and are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like PITPs, nor PITPs...

Descripción completa

Detalles Bibliográficos
Autores principales: Nile, Aaron H., Tripathi, Ashutosh, Yuan, Peihua, Mousley, Carl J., Suresh, Sundari, Wallace, Iain Michael, Shah, Sweety D., Pohlhaus, Denise Teotico, Temple, Brenda, Nislow, Corey, Giaever, Guri, Tropsha, Alexander, Davis, Ronald W., St Onge, Robert P., Bankaitis, Vytas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059020/
https://www.ncbi.nlm.nih.gov/pubmed/24292071
http://dx.doi.org/10.1038/nchembio.1389
Descripción
Sumario:Sec14-like phosphatidylinositol transfer proteins (PITPs) integrate diverse territories of intracellular lipid metabolism with stimulated phosphatidylinositol-4-phosphate production, and are discriminating portals for interrogating phosphoinositide signaling. Yet, neither Sec14-like PITPs, nor PITPs in general, have been exploited as targets for chemical inhibition for such purposes. Herein, we validate the first small molecule inhibitors (SMIs) of the yeast PITP Sec14. These SMIs are nitrophenyl(4-(2-methoxyphenyl)piperazin-1-yl)methanones (NPPMs), and are effective inhibitors in vitro and in vivo. We further establish Sec14 is the sole essential NPPM target in yeast, that NPPMs exhibit exquisite targeting specificities for Sec14 (relative to related Sec14-like PITPs), propose a mechanism for how NPPMs exert their inhibitory effects, and demonstrate NPPMs exhibit exquisite pathway selectivity in inhibiting phosphoinositide signaling in cells. These data deliver proof-of-concept that PITP-directed SMIs offer new and generally applicable avenues for intervening with phosphoinositide signaling pathways with selectivities superior to those afforded by contemporary lipid kinase-directed strategies.